Never Too Late: If you missed the IPKat last week!
Reviewed by
Asude Sena Moya
on
Wednesday, May 14, 2025
Rating:
5
Defining the undefinable: The challenges and opportunities for cell therapy IP
Reviewed by
Dr Rose Hughes
on
Tuesday, May 13, 2025
Rating:
5
AI and Copyright - the Kidron Amendments
Reviewed by
Oliver Fairhurst
on
Tuesday, May 13, 2025
Rating:
5
The never-ending story of Brexit – Chapter: EUIPO v Nowhere – Act I: The Advocate General’s Opinion
Reviewed by
Marcel Pemsel
on
Tuesday, May 13, 2025
Rating:
5
[Guest Post] A shotgun revocation? Did the South African court jump the gun in Regents of the University of California v Eurolab & Dis-Chem?
Reviewed by
Simone Lorenzi
on
Monday, May 12, 2025
Rating:
5
[Guest Post] Out the Door, Back In Through the Grille: Warsaw Court Reverses Audi Advantage
Reviewed by
Marcel Pemsel
on
Sunday, May 11, 2025
Rating:
5
UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21
Reviewed by
Annsley Merelle Ward
on
Friday, May 09, 2025
Rating:
5
Commercial success is a nothing-burger for the EPO in Wegovy patent inventive step analysis (T 1701/22, Obesity treatment with semaglutide)
Reviewed by
Dr Rose Hughes
on
Thursday, May 08, 2025
Rating:
5
Of tables and other furniture: AG Szpunar advises CJEU on originality (but also proposes adoption of recognizability test for infringement)
Reviewed by
Eleonora Rosati
on
Thursday, May 08, 2025
Rating:
5
Tuesday Tiddlywinks
Reviewed by
Eleonora Rosati
on
Tuesday, May 06, 2025
Rating:
5